Better policies for better lives The Organisation for Economic Co-operation and Development (OECD) is an international organisation that works to build better policies for better lives. We draw on more than 60 years of experience and insights to shape policies that foster prosperity and opportunity, underpinned by equality and well-being. We work closely with policy makers, stakeholders and citizens to establish evidence-based international standards and to find solutions to social, economic and environmental challenges. From improving economic performance and strengthening policies to fight climate change to bolstering education and fighting international tax evasion, the OECD is a unique forum and …

Sectors: International development

The official account of the French Government Follow Government news on this page in real time, including practical information, measures, numbers, results, and the profiles of economic players !

We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit www.astrazeneca.com. Community Guidelines: bit.ly/2MgAcio Pharmaceutical, Biopharmaceutical, Innovation, Research and development, and Global business

Sectors: Pharmaceutical

Founded in 1969, Cegedim is an innovative technology and services company in the field of digital data flow management for healthcare ecosystems and B2B, and a business software publisher for healthcare and insurance professionals. Cegedim employs 6,500 people in more than 10 countries and generated revenue of €616 million in 2023. Cegedim SA is listed in Paris (EURONEXT: CGM). To learn more, please visit: www.cegedim.com And follow Cegedim on X: https://bit.ly/3HCgucL & Facebook: https://bit.ly/42i5fji & Instagram: https://bit.ly/3vWKBt7 Solutions and Services for Healthcare Companies, Solutions and Services for Healthcare Professionals, and Solutions and Services for Corporate Businesses

Sectors: IT services

#WeareBiotech Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2024, Amgen …

Sectors: Biotechnology

AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html. Biopharmaceutical, Biotechnology, Innovation, Research and Development, Manufacturing, Biotherapeutics, Oncology, Immunology, Virology, Neuroscience, Womens Health, Aesthetics, and Eye Care

Sectors: Pharmaceutical

New ways to care Laboratoires Pierre Fabre held by the Pierre Fabre Foundation, is a worldwide company with a unique positioning : the alliance of pharmaceutical and dermocosmetics expertise. This makes Pierre Fabre Group : 💊 A pharmaceutical group with a strong positioning : medical and natural 🥈 The second largest dermo-cosmetics laboratory in the world 🥈 The second largest private French pharmaceutical group 🥇 The market leader in France for products sold over the counter in pharmacies. Our portfolio includes several medical franchises and international brands including ; Pharmaceutical Care Pierre Fabre Oncologie Pierre Fabre Dermatologie Naturactive Eau Thermale …

Sectors: Pharmaceutical

This channel is not intended for U.S. and Canadian visitors. Merck operates in the U.S. and Canada as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Electronics in Electronics. An unaffiliated and unrelated company, Merck & Co., Inc., Kenilworth, NJ, US holds the rights in the trademark MERCK in the U.S. and Canada. _______________________________ We are Merck, a leading global science and technology company headquartered in Germany. We are curious explorers, courageous pioneers, and ingenious inventors. Our colleagues across the globe love innovating with science and technology to enrich people’s lives with our solutions in Life Science, Healthcare, …

Tags: DAX30 Sectors: Biotechnology Pharmaceutical

As one of the largest global insurers, our purpose is to act for human progress by protecting what matters. Protection has always been at the core of our business, helping individuals, businesses and societies to thrive. And AXA has always been a leader, an innovator, an entrepreneurial company, fostering progress in all its dimensions. Our purpose also links back to the Group's roots. From the outset, AXA has been committed to acting as a force for collective good. From solidarity-based actions with AXA Hearts In Action to work on prevention issues with the AXA Research Fund and the fight against …

Tags: CAC40 Sectors: Insurance

We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare

Tags: CAC40 Sectors: Pharmaceutical

[Automatic translation follows] For safe, effective, innovative and accessible health products The National Agency for the Safety of Medicines and Health Products is the public actor that allows, on behalf of the State, access to health products in France and ensures their safety throughout their life cycle. At the heart of the health system, we act in the service of patients and their safety. We promote access to innovative products via authorization procedures adapted to each stage of the life of the drug before and after it is placed on the market. Through our assessments, our expertise and our monitoring …

[Automatic translation follows] The professional organization of pharmaceutical companies operating in France. Leem, Les Entreprises du médicament, brings together companies in the pharmaceutical industry sector in France. Created over 130 years ago, Leem now has nearly 270 member companies, which generate nearly 98% of the total pharmaceutical turnover in France. The pharmaceutical industry employs 100,000 people in over 150 professions, and has recruited 10,000 employees per year for the past 10 years. Each year, the pharmaceutical industry invests 12% of its turnover in research, in order to develop new innovative treatments. It brings together more than 20,000 people in its …

Sectors: Startup accelerator & VC

Innovation for Health Founded in 2005, the Medicen Paris Region global competitiveness cluster aims to position the Paris Region as a European industrial leader in diagnostic and therapeutic innovation and leading-edge health technologies, thus enabling it to become one of the global centres for translational medicine. Medicen Paris Region’s partnership approach is based on the concept of economic value creation in the Paris Region stimulated by innovation, which forms the very basis of the creation of competitiveness clusters and sets three main priorities: developing growth and employment in profitable markets in a successful dynamic relationship between YICs/SMEs, large firms and …

Sectors: French Cluster Public business cluster

Pôle de compétitivité santé du Grand Est Pôle de compétitivité Santé du Grand Est, BioValley France (ex Alsace BioValley) a pour mission de fédérer, développer et faire rayonner les acteurs de la filière à travers l’Innovation. Le Pôle s’appuie sur un réseau dynamique d’entreprises, une recherche académique et clinique de premier plan, ainsi qu’un réseau intégré de partenaires, acteurs-clés de l’innovation. BioValley France accompagne ses membres dans leur démarche d’Innovation R&D et leur permet d’accéder à des expertises à forte valeur ajoutée, dans une approche marché. BioValley France participe activement aux projets structurants et collaboratifs du territoire. Il contribue notamment …

Sectors: Biotechnology French Cluster Public business cluster

Our people are our strength. And, together with over 53,000 colleagues, we're creating the next breakthrough in the world of health and innovation for both humans and animals. Are you ready to join us? #LifeForward Privacy Notice: https://www.boehringer-ingelheim.com/privacy-notice Imprint: https://www.boehringer-ingelheim.com/imprint Pharmaceuticals, Animal Health, Innovation, Research, Health Care, Improve Health, Biopharmaceuticals, and Contract Manufacturing

Sectors: Animal Health Pharmaceutical

[Automatic translation follows] Working at Health Insurance means giving a new dimension to your job and acting every day to protect our health system. Participate in a wide variety of projects in a caring environment and be proud to contribute to an essential mission: acting together, protecting everyone. For nearly 80 years, Health Insurance has played a major role in serving national solidarity. We are convinced that the key to the sustainability of the health system is a collective responsibility and lies in the strong involvement of each of its stakeholders. Within this system, Health Insurance has a triple mission: …

Sectors: Insurance

Get more done with faster, more productive AI and analytics from the most trusted analytics partner on the planet. Get more done with faster, more productive AI and analytics from the most trusted analytics partner on the planet. Produce answers as fast as the world produces data with SAS. With over forty years of analytics innovation, SAS has been giving customers around the world THE POWER TO KNOW®. SAS, BI, Data Mining, Analytics, Business Analytics, Predictive Analytics, Statistics, Customer Intelligence, Enterprise Risk Management, AI, artificial intelligence, speed, productivity, SAS Viya, and cloud

Sectors: IT services

At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse …

Sectors: Pharmaceutical

Ceva Santé Animale (Ceva) is the 5th global animal health company, led by experienced veterinarians, whose mission is to provide innovative health solutions for all animals to ensure the highest level of care and well-being. Our portfolio includes preventive medicine such as vaccines and animal welfare products, pharmaceutical solutions for farm and companion animals, as well as equipment and services to provide the best experience for our customers. With more than 7,000 employees located in 47 countries, Ceva strives daily to bring to life its vision as a One Health company: “Together, beyond animal health”. Our 21 R&D centers and …

Sectors: Animal Health Pharmaceutical

We match international investors, business professionals, founders, talents and visitors with possibilities in Helsinki. Helsinki Partners is a city marketing, investment and talent attraction company owned by the City of Helsinki. Whether you’re looking to set up or expand your company, find quality deal flow and investment opportunities, the best location for your event or congress, or visit or find your new career in Finland’s capital, Helsinki, we are here to help. Our mission: Our mission is to promote the city’s sustainable growth and build Helsinki’s global reputation and brand. We do this by attracting international investments, businesses, talents and …

Sectors: Startup accelerator & VC

Where people who know first, go first. FirstWord Pharma is a trusted news and analysis service that keeps pharmaceutical professionals up-to-date with the latest industry news and intelligence from across the globe. Fast and reliable news delivery of the latest developments in the pharma industry, with related analyses, physician polls and executive interviews to provide deeper insights. Never miss the critical developments shaping the industry with news and analysis delivered to your inbox daily. Register for our free daily industry newsletter at https://www.firstwordpharma.com/register FirstWord Pharma+, our personalized premium news service, allows you to monitor and track specific compounds/products, companies, medical …

Sectors: Pharmaceutical

At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, …

Sectors: Pharmaceutical

Teva Pharmaceuticals has been developing and producing medicines to help improve people’s lives for more than a century. We are committed to being a global leader in generic and specialty medicines with a portfolio of 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day. They are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products. Learn more at www.tevapharm.com. Please …

Sectors: Pharmaceutical

We bring together the best of technology and our people to supercharge progress. HCLTech is a global technology company, home to more than 218,000 people across 59 countries, delivering industry-leading capabilities centered around digital, engineering, cloud and AI, powered by a broad portfolio of technology services and products. We work with clients across all major verticals, providing industry solutions for Financial Services, Manufacturing, Life Sciences and Healthcare, Technology and Services, Telecom and Media, Retail and CPG, and Public Services. Consolidated revenues as of 12 months ending September 2024 totaled $13.7 billion. To learn how we can supercharge progress for you, …

At Johnson & Johnson, we believe health is everything. As a focused healthcare company, with expertise in Innovative Medicine and MedTech, we’re empowered to tackle the world’s toughest health challenges, innovate through science and technology, and transform patient care. ​ All of this is possible because of our people. We’re passionate innovators who put people first, and through our purpose-driven culture and talented workforce, we are stronger than ever. ​ Learn more at https://www.jnj.com. Community Guidelines: http://www.jnj.com/social-media-community-guidelines Health Care, Medical Devices & Diagnostics, and Pharmaceuticals

Sectors: Pharmaceutical

The official #EUGreenCapital and #EUGreenLeaf Awards. Our aim is to improve Europe's urban environment. The European Green Capital and European Green Leaf awards are a European Commission initiative to recognise a city's commitment to a better urban environment. Cities with populations over 100,000 inhabitants are eligible to apply for the European Green Capital Award while the European Green Leaf is open to cities of between 20,000 and 100,000 inhabitants. Winners demonstrate well-established records of high environmental standards and a commitment to setting ambitious goals for future environmental progress, underpinned by the practical application of sustainable development. The schemes have a …

Sectors: European Union

[Automatic translation follows] Tailor-made support for your innovation projects The Technology Transfer Acceleration Company (SATT) – Ouest Valorisation SAS was created on July 20, 2012 as part of the Investments for the Future. Its mission is to accelerate the transfer of research results from public research laboratories to partners: VSEs/SMEs, large groups, local authorities, associations. It thus supports researchers working in 28 higher education institutions (universities, engineering schools and university hospitals) as well as 3 research organizations located in one of the university centers of Brittany or Pays de la Loire (Angers, Brest, Le Mans, Lorient-Vannes, Nantes, Rennes). With 70 …

Tags: SATT Network Sectors: Research Startup accelerator & VC

[Automatic translation follows] EMBARK AT THE HEART OF THE FRENCH EXCELLENCE SECTOR Created in 1908, the Groupement des Industries Françaises Aéronautiques et Spatiales (GIFAS) is a professional union that brings together 482 companies, from major project managers and system makers to SMEs and startups. Its members constitute a coherent, united and dynamic high-tech sector specializing in the study, development, production, marketing and maintenance of all aeronautical and space programs and equipment, civil and military, as well as defense and security systems. GIFAS represents a profession with a 2023 turnover of €70.2 billion, with 83% of consolidated turnover from exports, and …

The European Parliament is the only EU body directly elected by citizens. The European Parliament is the elected body of the European Union. The Parliament consists of 720 members elected by citizens in EU countries. The Members work in close unison with the Commission and the Council in shaping the laws and policies of the EU. Follow our Linkedin page and newsletter to get the latest updates from the European Parliament. Privacy statement: https://www.europarl.europa.eu/website/files/Privacy_statement_Social_media_usage.pdf COMMUNITY GUIDELINES ================================== We encourage all forms of discussion on this page. Please keep in mind the following guidelines while participating. We want our page to …

Sectors: European Union

[Automatic translation follows] Benefit from an expert system for innovation in Biotechs, Medtechs and industry 4.0. The TEMIS technology park is an ecosystem in Besançon by bringing together and promoting synergies between the economic, academic, scientific and training sectors to generate ideas and innovation projects. The Besançon technology park offers 250 ha of expertise on 2 sites: TEMIS Santé specializing in biomedical, biotherapies and bioproduction... with the BIO INNOVATION center as the embodiment of the current dynamics. A point of contact for accessing the resources, equipment, expertise and know-how essential to defining and conducting projects relating to the medicine of …

Our mission is to deliver the greatest possible impact to people through mRNA medicines. At Moderna, we believe messenger RNA, or mRNA, is the “software of life.” Every cell in the body uses mRNA to provide real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease. Given its essential role, we believe mRNA could be used to create a new category of medicines with significant potential to improve the lives of patients. We are pioneering a new class of medicines made of messenger RNA, or mRNA. The potential implications of using …

Sectors: Biotechnology Pharmaceutical

Creating Possible At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy health inequities and break down barriers to care. We empower our people to tackle these challenges, and we’re all united in our commitment to help millions of people live healthier lives. Social Media Guidelines: https://www.gilead.com/social-media-guidelines

Sectors: Biotechnology Pharmaceutical

We are uniting science, technology and talent to get ahead of disease together. Our community guidelines: https://gsk.to/socialmedia Pharmaceutical products and Vaccines

Sectors: Pharmaceutical

Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki Cardiovascular, Immunology, Neuroscience, Solid Tumors, Hematology, Chemistry, xRNA, Radioligand, and Gene and cell therapy

Sectors: Pharmaceutical

Servier is a privately held international pharmaceutical company headquartered in France with a passion for innovation that has improved patients’ lives around the world. With $4.7 billion in annual sales Servier operates in almost 150 countries worldwide across five therapeutic categories including oncology, cardiovascular, immuno-inflammatory, neuroscience and diabetes. Servier is founded on the principle of serving and governed by an independent non-profit foundation. With this unique operating model, the company can be deliberate about putting patients ahead of profits. In fact, Servier re-invests 25 percent of revenue into research and development each year. Servier is committed to therapeutic progress to …

Sectors: Pharmaceutical

[Automatic translation follows] If you need general and specialized information about Madrid's public services, you can call the Citizens' Helpline 012. In the Community of Madrid we are delighted to receive comments and encourage dialogue, so we propose some basic rules for participation: - Respect other users and make appropriate use of the network when posting a comment. Any defamatory, offensive, threatening, rude message or any message that is punishable by Spanish law will be deleted. - Make comments related to what is posted, be as brief as possible and avoid capital letters. Comments that are considered off-topic will be …

Sectors: National and local authorities

Bayer is a global enterprise with core competencies in the life science fields of healthcare and nutrition. We design our products and services to serve the most essential human needs of health and nutrition. At the same time, we strive to address some of the world’s biggest challenges presented by a growing and aging global population. At Bayer, we’re committed to driving sustainable development and generate a positive impact with our businesses. Through the power of science, we’re pioneering new possibilities that advance life for all of us. That means reimagining how we care for ourselves and one another by …

Tags: DAX30 Sectors: Chemistry Pharmaceutical

The Network is the Computer. Sun Microsystems, Inc. is a wholly owned subsidiary of Oracle Corporation. Oracle Corporation, an enterprise software company, engages in the development, manufacture, distribution, servicing, and marketing of database, middleware, and application software worldwide. With the acquisition of Sun Microsystems, Oracle also owns Solaris, Java, MySQL and the Sun line of storage, server and network hardware. Virtualization, Cloud Computing, and End User Computing

Sectors: IT services

Offering talent leaders the reach of a marketing leader, forecast of a sales leader, and insight of a finance leader. Lever is a leading Talent Acquisition Suite that makes it easy for talent teams to reach their hiring goals and to connect companies with top talent. Lever is the only platform that provides all talent acquisition leaders with complete ATS and robust CRM capabilities in one product, LeverTRM. The Lever Hire and Lever Nurture features allow leaders to scale and grow their people pipeline, build authentic and long-lasting relationships, and source the right people to hire. Lever Analytics provides customized …

Sectors: Consumer Goods Food

Aiming to promote nuclear disarmament and non-proliferation and the strengthening of the disarmament regimes. The Office for Disarmament Affairs supports multilateral efforts aimed at achieving the ultimate goal of general and complete disarmament under strict and effective international control.

Sectors: International development

We’re celebrating 175 years of daring scientific innovation—and we’re not done yet. Every day, we’re channeling our passion and resources into delivering innovative therapies that change the face of healthcare. Let’s outdo yesterday. Follow our progress as we accelerate the next generation of cancer treatments at LetsOutdoCancer.com For additional information on our guidelines, please visit http://www.pfizer.com/community-guidelines To apply science and our global resources to improve health and well-being at every stage of life. We strive to provide access to safe and effective and affordable medicines and health care services to the people who need them.

Sectors: Pharmaceutical